open access
Ganglion Impar block improves neuropathic pain in coccygodynia: A preliminary report
Affiliations- Department of Physical Medicine and Rehabilitation, Division of Pain Medicine, Marmara University Pendik Training and Research Hospital, Istanbul, Türkiye
- Department of Physical Medicine and Rehabilitation, Marmara University Pendik Training and Research Hospital, Istanbul, Türkiye
- Department of Physical Medicine and Rehabilitation, Kayseri Training and Research Hospital, Kayseri, Türkiye
- Department of Physical Medicine and Rehabilitation, Adiyaman University Training and Research Hospital, Adiyaman, Türkiye
- Department of Physical Medicine and Rehabilitation, Division of Pain Medicine, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Türkiye
open access
Abstract
To define the effectiveness of ganglion Impar block in improving neuropathic pain.
Materials and methodsPatients who had pain around the coccyx for more than three months and did not respond to conservative treatment were included in this study. All the patients underwent fluoroscopy guided transsacrococcygeal ganglion Impar block with injecting 3 mL of 0.5% bupivacaine, 2 mL saline, and 1 mL (40 mg) of methylprednisolone. Patients were evaluated with visual analog scale (VAS) for pain, Leeds assessment of neuropathic symptoms and signs scale (LANSS) for neuropathic pain, Beck depression Inventory (BDI) for mood and Short-form 12 (SF-12) for quality of life before, 1 month 3 months and 6 months after the injection. Patients’ painless sitting duration was also recorded.
ResultsA total of 28 patients were included in the final analyses. VAS and LANSS scores improved significantly throughout the follow-up periods. BDI scores also improved while SF-12 scores did not show significant changes. Painless sitting period of the patients’ improved significantly.
ConclusionsGanglion Impar block is effective in decreasing the neuropathic component of chronic coccygodynia. This improves painless sitting in patients but its reflections on quality of life is not clear.
Abstract
To define the effectiveness of ganglion Impar block in improving neuropathic pain.
Materials and methodsPatients who had pain around the coccyx for more than three months and did not respond to conservative treatment were included in this study. All the patients underwent fluoroscopy guided transsacrococcygeal ganglion Impar block with injecting 3 mL of 0.5% bupivacaine, 2 mL saline, and 1 mL (40 mg) of methylprednisolone. Patients were evaluated with visual analog scale (VAS) for pain, Leeds assessment of neuropathic symptoms and signs scale (LANSS) for neuropathic pain, Beck depression Inventory (BDI) for mood and Short-form 12 (SF-12) for quality of life before, 1 month 3 months and 6 months after the injection. Patients’ painless sitting duration was also recorded.
ResultsA total of 28 patients were included in the final analyses. VAS and LANSS scores improved significantly throughout the follow-up periods. BDI scores also improved while SF-12 scores did not show significant changes. Painless sitting period of the patients’ improved significantly.
ConclusionsGanglion Impar block is effective in decreasing the neuropathic component of chronic coccygodynia. This improves painless sitting in patients but its reflections on quality of life is not clear.
Keywords
Coccygodynia, Ganglion Impar, Neuropathic pain, Sympathetic block
About this articleTitle
Ganglion Impar block improves neuropathic pain in coccygodynia: A preliminary report
Journal
Neurologia i Neurochirurgia Polska
Issue
Pages
612-617
Published online
2018-08-28
Page views
394
Article views/downloads
611
DOI
10.1016/j.pjnns.2018.08.006
Bibliographic record
Neurol Neurochir Pol 2018;52(5):612-617.
Keywords
Coccygodynia
Ganglion Impar
Neuropathic pain
Sympathetic block
Authors
Savas Sencan
Ozge Kenis-Coskun
Fatma Gul Ulku Demir
Isa Cuce
Tulay Ercalık
Osman Hakan Gunduz
